Insider · CIK 0002007219
Ryan Alexander Jones
Files at KYTX (Kyverna Therapeutics, Inc.). First filing -, latest -.
In brief
Ryan Alexander Jones files SEC Form 4 as CFO at KYTX (Kyverna Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ryan Alexander Jones has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 55,950 | Apr 15, 2025 |
| Apr 11, 2024 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +74,000 | $0.00 | $0 | 74,000 | Apr 15, 2025 |
Questions about Ryan Alexander Jones
Answered from the filings on this page, as of the latest one.
Is Ryan Alexander Jones buying or selling?
Ryan Alexander Jones has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ryan Alexander Jones's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ryan Alexander Jones has 0.
Where does Ryan Alexander Jones file Form 4?
Ryan Alexander Jones has filed Form 4 at KYTX (Kyverna Therapeutics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.